Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial. - Monjazeb AM; Daly ME; Luxardi G; Maverakis E; Merleev AA; Marusina AI; Borowsky A; Mirhadi A; Shiao SL; Beckett L; Chen S; Eastham D; et al. (Nature communications, 2023)